POCARED Diagnostics: Funding, Investors & Team (Sep 2026)
POCARED DiagnosticsTM is an in-vitro diagnostics company developing a next generation microbiology platform. POCAREDTM is revolutionizing infectious disease diagnosis with CULTURE-FREE MicrobiologyTM POCARED’sTM P-1000TM; a platform that is fully automated, reagent free, real time, and easy to operate. POCARED'TM saves several critical days in result reporting by providing multi-source detection, quantification and species identification results for bacteria and yeast in few minutes, directly from the specimen.
POCARED Diagnostics has raised $23.1M across 1 funding round on record, the most recent a Debt Financing of $23.1M announced in May 2022.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
POCARED Diagnostics Company Profile and Key Stats
Latest funding round on record: May 2022.
POCARED Diagnostics Funding Rounds
POCARED Diagnostics Founders and Leadership Team
Contact details for the POCARED Diagnostics team: 1 of 1 has an email address on file.
Start 14-day free trial →POCARED Diagnostics Funding Compared to Other Biotechnology Startups
POCARED Diagnostics' latest round of $23.1M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like POCARED Diagnostics in Biotechnology and Rehovot
Companies Similar to POCARED Diagnostics
CollPlant is a regenerative medicine company that focuses on 3D bioprinting of tissues and organs and also…
Magdent’s novel technology utilizes electromagnetic fields, PEMF technology, to stimulate, accelerate, and…
Brevel has created an innovative method of cultivating microalgae that is both sustainable and…
RedHill Biopharma Ltd. (NASDAQ: RDHL) is a specialty biopharmaceutical company primarily focused on…
Regentis Biomaterials is a privately held company focused on developing and commercializing proprietary…
IceCure Medical is a medical device company setting new standards in minimally-invasive tumor therapy for…
Splisense is develops antisense oligonucleotide based therapies to target genetic diseases caused by splicing…
Phytolon is transforming the process of creating food colors by using an innovative and environmentally…
BlueWind Medical develops and markets a wireless neurostimulation device for the treatment of peripheral…
SuperMeat is an Israeli bio-tech and food-tech organization, fostering an innovation to make clean meat from…
ECOncrete technology provides sustainable solutions for construction of ecologically active infrastructures,…
MSICS Pharma is a pharmaceutical company that manufactures and produce naturally-sourced Psilocybin for…
POCARED Diagnostics Funding FAQs
What does POCARED Diagnostics do?
POCARED DiagnosticsTM is an in-vitro diagnostics company developing a next generation microbiology platform. POCAREDTM is revolutionizing infectious disease diagnosis with CULTURE-FREE MicrobiologyTM POCARED’sTM P-1000TM; a platform that is fully automated, reagent free, real time, and easy to operate. POCARED'TM saves several critical days in result reporting by providing multi-source detection, quantification and species identification results for bacteria and yeast in few minutes, directly from the specimen.
How much funding has POCARED Diagnostics raised?
POCARED Diagnostics has raised $23.1M across 1 round on record. The most recent is a Debt Financing of $23.1M announced in May 2022.
When did POCARED Diagnostics last raise funding?
POCARED Diagnostics' most recent funding round on record is a Debt Financing of $23.1M, announced in May 2022.
Who is the CEO of POCARED Diagnostics?
Jonathan Gurfinkel is listed as CEO at POCARED Diagnostics.
Where is POCARED Diagnostics headquartered?
POCARED Diagnostics is based in Rehovot, Hamerkaz, Israel.
How many employees does POCARED Diagnostics have?
POCARED Diagnostics is in the 11-50 employee band.
How does POCARED Diagnostics' funding compare to other Biotechnology startups?
POCARED Diagnostics' latest round of $23.1M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's POCARED Diagnostics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for POCARED Diagnostics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.